Douglas Lane & Associates LLC Sells 178 Shares of The Procter & Gamble Company (NYSE:PG)

Douglas Lane & Associates LLC reduced its position in The Procter & Gamble Company (NYSE:PG) by 0.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,158 shares of the company’s stock after selling 178 shares during the quarter. Douglas Lane & Associates LLC’s holdings in Procter & Gamble were worth $3,379,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the business. International Assets Investment Management LLC lifted its position in shares of Procter & Gamble by 19,030.8% in the 3rd quarter. International Assets Investment Management LLC now owns 3,693,593 shares of the company’s stock worth $639,730,000 after purchasing an additional 3,674,286 shares during the period. Wulff Hansen & CO. raised its stake in Procter & Gamble by 16,292.0% in the second quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company’s stock worth $606,230,000 after buying an additional 3,653,477 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Procter & Gamble by 7.0% during the third quarter. Geode Capital Management LLC now owns 55,204,776 shares of the company’s stock worth $9,538,327,000 after buying an additional 3,619,466 shares during the period. Franklin Resources Inc. boosted its position in Procter & Gamble by 10.2% during the 3rd quarter. Franklin Resources Inc. now owns 18,988,721 shares of the company’s stock valued at $3,290,573,000 after acquiring an additional 1,760,214 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new position in shares of Procter & Gamble in the 3rd quarter valued at $301,950,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Trading Up 0.5 %

Shares of Procter & Gamble stock opened at $162.07 on Thursday. The Procter & Gamble Company has a 1 year low of $146.28 and a 1 year high of $180.43. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The stock has a market cap of $381.68 billion, a PE ratio of 27.94, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45. The firm has a fifty day moving average price of $169.83 and a 200 day moving average price of $169.70.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company’s revenue for the quarter was down .6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.83 EPS. Equities research analysts predict that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on PG. DA Davidson restated a “buy” rating and set a $209.00 price objective on shares of Procter & Gamble in a research note on Friday, December 27th. Royal Bank of Canada restated a “sector perform” rating and issued a $164.00 price target on shares of Procter & Gamble in a report on Monday, October 21st. Evercore ISI boosted their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. Piper Sandler assumed coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 target price for the company. Finally, Morgan Stanley upped their price target on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Eight research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $179.75.

Insider Transactions at Procter & Gamble

In other news, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the sale, the chief executive officer now directly owns 39,977 shares in the company, valued at $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO R. Alexandra Keith sold 1,992 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the transaction, the chief executive officer now owns 13,783 shares in the company, valued at $2,343,110. This trade represents a 12.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 75,439 shares of company stock valued at $13,317,460 in the last 90 days. 0.18% of the stock is currently owned by company insiders.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.